Humanigen Inc expected to post a loss of 6 cents a share - Earnings Preview

Humanigen

24/02/2023 11:01

* Humanigen Inc  HGEN.OQ   HGEN.O  is expected to show a
fall in
quarterly revenue when it reports  results on February 27
(estimated). 
    * The Short Hills New Jersey-based  company is expected to
report 
a 90.4% decrease in revenue to $100 thousand from $1.04 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Humanigen Inc is
for a
loss of 6 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Humanigen
Inc is
$0.5​, above​ its last closing price of $0.16. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.18       -0.18      -0.23     Missed  -27.4
 Jun. 30 2022  -0.31       -0.30      -0.43     Missed  -45.4
 Mar. 31 2022  -0.47       -0.46      -0.32     Beat    30.8​
 Dec. 31 2021  -0.68       -0.65      -0.53     Beat    18
 ​​Sep.        -1.01       -0.98      -1.12     Missed  -13.8
 30 2021                                                
 Jun. 30 2021  -0.83       -0.86      -1.20     Missed  -39.3​
 Mar. 31 2021  -0.71       -0.64      -1.25     Missed  -95.3
 Dec. 31 2020  -0.68       -0.67      -0.63     Beat    6.3
 This summary was machine generated February 24 at 11:01 GMT. 
All figures in US dollars  unless otherwise stated